← Open Payments lookup

WARREN YAMASHITA: Open Payments

NPI 1982137691 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$807 in 32 payments from 14 companies in 2025. Trend: 2023 $24 · 2024 $465 · 2025 $807

Food & beverage: $807
CompanyPaymentsAmount
ABBVIE INC.9$200
ViiV Healthcare Company3$100
Gilead Sciences, Inc.4$87
Indivior Inc.2$59
Sage Therapeutics, LLC2$56
Braeburn Inc.2$55
Lilly USA, LLC2$46
Amgen Inc.2$46
Madrigal Pharmaceuticals1$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$29

Products named: MAVYRET, APRETUDE, VRAYLAR, SUBLOCADE, ZURZUVAE, BRIXADI, OTEZLA, REZDIFFRA.

Industry payments across CA — which companies pay providers there.